Regulatory Compliance Portal

We manufactures products for diverse global markets, each with its own regulatory framework. While balliacorpus.com does not provide detailed product specifications, we maintain a Regulatory Compliance Portal (available by request) that summarizes the status of our approvals and certifications in key jurisdictions. Highlights include:

1. India (FSSAI) – Our facilities are registered with the Food Safety and Standards Authority of India (FSSAI). We comply with Indian food and dietary supplement regulations, including labelling and ingredient restrictions.

2. United States (FDA) – We operate in accordance with the U.S. Food and Drug Administration’s regulations for dietary supplements (21 CFR 111/117). Our processes meet Good Manufacturing Practice (GMP) requirements, and we implement quality controls consistent with FDA guidance. While we are not FDA‑approved as a pharmaceutical manufacturer, our dietary supplements are manufactured in FDA‑registered facilities.

3. European Union – We comply with the EU’s Novel Food regulation where applicable, and our cosmetic products meet EU Cosmetic Regulations. We also adhere to REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) obligations for substances in our products.

4. Australia (TGA) – For products intended for Australia, we work with clients to ensure compliance with the Therapeutic Goods Administration (TGA) and relevant categories under the Australian Register of Therapeutic Goods.

5. Other Regions – We support regulatory submissions and compliance for Canada (Health Canada), Middle Eastern authorities (e.g., SFDA), Latin America (ANVISA and COFEPRIS) and other jurisdictions. Specific requirements vary and are addressed in contractual engagements.

This portal is periodically updated and is available to clients upon request under a non‑disclosure agreement.